https://www.selleckchem.com/pr....oducts/Rapamycin.htm
BACKGROUND Breast augmentation in primary or secondary patients with long lower pole lengths but appropriately sited nipples is at high risk of "bottoming out" following surgery. The lower pole mastopexy-augmentation (LPMA) was developed to correct long lower pole lengths or preempt bottoming out in breasts deemed at risk, avoiding the requirement for periareolar and vertical breast scar, as well as minimizing the requirement for the use of synthetic mesh. OBJECTIVES The goal of this short report was to analyze outcomes in cases under